Kimon is the founder of Vivante Health, which was created in early 2016, after he left Livongo, to tackle the needs of people who have invisible and stigmatized diseases, who have been neglected in the healthcare system. Prior to his healthcare career, Kim was the Chief Strategic Officer at Tanox, Inc which sold to Genentech (NYSE: DNA) for $1B, Director of Strategic Development at St Luke’s/Texas Heart Institute, Professor and Chair of Cell Biology and Biomedical Sciences at the University of Durham in the UK, Professor of Cell Biology, Neuroscience, Biochemistry, and Molecular Biophysics at Baylor College of Medicine, and Associate and Assistant Professor at the University of Florida and McGill University. Kim has served on the National Medical Advisory Boards of the National Multiple Sclerosis Society, Muscular Dystrophy Association, and the National Institutes of Health. He has published over 100 papers and holds more than 40 patents. He received a PhD in Chemistry from the University of California and has done graduate study in business, laws, and public health.